- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVS
Recent news which mentions NVS
From Benzinga
3 Under-the-Radar COVID Stocks
October 20, 2021
From Motley Fool
Is This Beaten Down Biotech a Bad News Buy?
October 20, 2021
From Motley Fool
From Benzinga
From Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
From Benzinga
3 No-Brainer Stocks to Buy Right Now
October 14, 2021
From Motley Fool
3 Growth Stocks Near 52-Week Highs to Buy Anyway
October 14, 2021
From Motley Fool
From InvestorPlace
Why CRISPR Therapeutics Stock Is Sinking Today
October 13, 2021
From Motley Fool
For Patient Investors, Tilray Will Deliver Multi-Fold Returns
October 13, 2021
From InvestorPlace
eFFECTOR Therapeutics Stock Gains On Encouraging Preclinical Zotatifin Data In Breast Cancer
October 08, 2021
From Benzinga
From Benzinga
Novartis Posts New Data Reinforcing Efficacy, Convenience Of Cosentyx Autoinjector In Psoriasis
September 29, 2021
Tickers
NVS
From Benzinga
This Potential Indication Could Be a Winner for Novartis
September 29, 2021
From Motley Fool
7 Biotech Stocks Entering the Golden Boom Phase
September 28, 2021
From InvestorPlace
Green Hygienics Holdings To Raise $100M Via Green Bond Offering
September 22, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
Novartis Adds Vision Loss Gene Therapy Program Via Arctos Acquisition
September 21, 2021
Tickers
NVS
From Benzinga
Why Did Deutsche Bank Downgrade This Big Pharma Stock?
September 20, 2021
From Benzinga
Novartis' Kisqali Combo Therapy Extends Survival By One Year In Breast Cancer Patients
September 20, 2021
Tickers
NVS
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021
September 20, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
From Benzinga
Novartis' Prostate Cancer Therapy Linked To Improved Quality Of Life
September 17, 2021
Tickers
NVS
From Benzinga
Zymeworks' Zanidatamab Aces Mid-Stage Esophageal Cancer Trial
September 16, 2021
From Benzinga
3 Top Chinese Stocks to Watch in September
September 15, 2021
From Motley Fool
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
September 14, 2021
From Benzinga
Why Regenxbio Stock Is Way Up Today
September 13, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.